CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company
Aptevo Therapeutics Inc.
Sign in to watch- Ticker
- APVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 811567056
- Phone
- 206-838-0500
- Business address
- 2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-01 | Kwon SoYoung SVP, GC and Corporate Affairs | Option exercise · Restricted Stock Unit | −1,833 | 3,667 | ||
| 2022-06-01 | Harsanyi Zsolt Director | Option exercise | +298 | 4,607 | ||
| 2022-06-01 | Harsanyi Zsolt Director | Option exercise · Restricted Stock Unit | −298 | 595 | ||
| 2022-06-01 | Niederhuber John Director | Option exercise | +298 | 1,814 | ||
| 2022-06-01 | Niederhuber John Director | Option exercise · Restricted Stock Unit | −298 | 595 | ||
| 2022-06-01 | Kunz Barbara Lopez Director | Option exercise | +298 | 1,012 | ||
| 2022-06-01 | Kunz Barbara Lopez Director | Option exercise · Restricted Stock Unit | −298 | 595 | ||
| 2022-06-01 | Grant Grady III Director | Option exercise | +298 | 1,012 | ||
| 2022-06-01 | Grant Grady III Director | Option exercise · Restricted Stock Unit | −298 | 595 | ||
| 2022-03-04 | White Marvin L President and CEO | Grant or award · Stock Option (right to buy) | +28,750 | 28,750 | ||
| 2022-03-04 | Lamothe Jeffrey G. CFO | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2022-03-04 | Kwon SoYoung SVP, GC, and Corporate Affairs | Grant or award · Stock Option (right to buy) | +11,000 | 11,000 | ||
| 2022-01-29 | White Marvin L President and CEO | Option exercise | +4,792 | 25,764 | ||
| 2022-01-29 | White Marvin L President and CEO | Option exercise · Restricted Stock Unit | +4,792 | 9,583 | ||
| 2022-01-29 | Lamothe Jeffrey G. SVP and CFO | Option exercise | +1,833 | 7,192 | ||
| 2022-01-29 | Lamothe Jeffrey G. SVP and CFO | Option exercise · Restricted Stock Unit | +1,833 | 3,667 | ||
| 2021-12-03 | El-Hibri Fuad Director | Other acquisition | +107,807 | 107,807 | ||
| 2021-12-03 | El-Hibri Fuad Director | Other acquisition | +9,819 | 9,819 | ||
| 2021-12-03 | El-Hibri Fuad Director | Other acquisition | +7,373 | 7,373 | ||
| 2021-11-23 | TANG KEVIN C Exit Filing | Sale | −161,336 | $13.52 | $2.2M | 760,000 |
Page 11 of 27 · 523 trades